Berenberg Bank reaffirmed their hold rating on shares of Mediclinic International (LON:MDC – Get Rating) in a research note issued to investors on Tuesday, MarketBeat.com reports. Berenberg Bank currently has a GBX 464 ($5.68) target price on the stock.
Separately, Barclays raised their price objective on Mediclinic International from GBX 385 ($4.72) to GBX 460 ($5.63) and gave the company an overweight rating in a research note on Tuesday, May 31st.
LON:MDC opened at GBX 445.80 ($5.46) on Tuesday. The stock has a market capitalization of £3.29 billion and a P/E ratio of 21.76. The stock has a 50-day moving average price of GBX 388.74 and a 200 day moving average price of GBX 351.21. The company has a current ratio of 1.79, a quick ratio of 1.67 and a debt-to-equity ratio of 79.76. Mediclinic International has a 12-month low of GBX 271.40 ($3.32) and a 12-month high of GBX 458.20 ($5.61).
In related news, insider Tom Singer acquired 20,000 shares of the firm’s stock in a transaction dated Wednesday, May 25th. The stock was acquired at an average price of GBX 366 ($4.48) per share, with a total value of £73,200 ($89,661.93).
Mediclinic International Company Profile (Get Rating)
Mediclinic International plc, together with its subsidiaries, operates private hospitals. The company offers acute care, specialist-orientated, and multidisciplinary healthcare services under the Mediclinic and Hirslanden brand names. It operates 74 hospitals, 18 day case clinics, 18 outpatient clinics, 5 subacute hospitals, 2 mental health facilities, and 454 theatres with approximately 11,?449 inpatient beds in Switzerland, South Africa, Namibia, and the United Arab Emirates.
- It’s A Comfortable Time To Buy Steelcase
- Worthington Posts Strong Results, But Earnings Fall On One-Off Adjustments
- A Tasty Entry Point Into Darden Restaurants International
- NXP Semiconductors: Strong Earnings & New Microcontrollers for Electric Vehicles
- Lithium Stocks Are Offering Unprecedented Opportunity To Investors
Receive News & Ratings for Mediclinic International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mediclinic International and related companies with MarketBeat.com's FREE daily email newsletter.